...
首页> 外文期刊>Combinatorial Chemistry & High Throughput Screening >Nucleic Acids for Recognition and Catalysis Landmarks, Limitations, and Looking to the Future
【24h】

Nucleic Acids for Recognition and Catalysis Landmarks, Limitations, and Looking to the Future

机译:核酸用于识别和催化的里程碑,局限性以及对未来的展望

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Combinatorial selection of nucleic acids has led to the discovery of novel ligands and catalysts that have implications for both chemistry and medicine. In the context of combinatorial chemistry, degenerate syntheses of nucleic acid libraries readily generate as many as 1015 different molecules in which a small percentage exhibit interesting binding and/or catalytic properties. The primary advantage of nucleic acids is that library coding is an intrinsic property; sequential composition directly determines the activity. At low temperatures, the sequential composition of single stranded nucleic acids governs folding into irregular tertiary structures resulting in interesting activities. At higher temperatures, the same structures are unfolded and decoded by polymerases to reveal sequential information. The use of PCR (polymerase chain reaction) permits amplification and thus enrichment of the selected activity which is then regenerated chemi-enzymatically. Iterative selection and amplification result in one of the highest throughput screens conceivable whereby each molecule encodes its own activity permitting the ultimate in parallel sampling. Finally, sequence information, and by extension the chemical composition, is obtained by simple sequencing techniques obviating the need for mass spectrometric deconvolution, parallel tagging, and/or large volumes needed for viral and cell culture. This review begins with an introduction of general concepts and considerations. The potential for nucleic acids to generate tight-binding ligands is of interest to structural biologists and medicinal chemists. The therapeutic implications to medicine are also touched upon. Since combinatorially selected nucleic acids and antibodies share many conceptual similarities, their respective advantages and limitations are compared. Theoretical and practical limitations for catalyst discovery are discussed along with the use of other chemical and physical approaches to address some current catalytic shortcomings. Finally some futu re directions are suggested.
机译:核酸的组合选择导致发现了对化学和医学都有影响的新型配体和催化剂。在组合化学的背景下,核酸文库的简并合成容易产生多达1015种不同的分子,其中一小部分表现出令人感兴趣的结合和/或催化特性。核酸的主要优点是文库编码是一种内在特性。顺序组成直接决定活动。在低温下,单链核酸的顺序组成决定折叠成不规则的三级结构,从而引起有趣的活动。在较高的温度下,相同的结构会被聚合酶解开并解码,以揭示顺序信息。 PCR(聚合酶链反应)的使用允许扩增并因此富集所选择的活性,然后将其化学化学地再生。迭代选择和扩增导致可想到的最高通量筛选之一,从而每个分子编码其自身的活性,从而允许最终平行采样。最后,可通过简单的测序技术获得序列信息,并通过扩展化学成分来获得,而无需进行质谱解卷积,并行标记和/或病毒和细胞培养所需的大量样品。这篇综述首先介绍了一般概念和注意事项。核酸产生紧密结合的配体的潜力是结构生物学家和药物化学家感兴趣的。还涉及到药物的治疗意义。由于组合选择的核酸和抗体具有许多概念相似性,因此比较了它们各自的优点和局限性。讨论了发现催化剂的理论和实际局限性,以及使用其他化学和物理方法来解决当前一些催化缺陷。最后,提出了一些未来的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号